Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra rescue treatment for allergic airway inflammation
NCT03513471Phase 2Withdrawn
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Aug 2019
- Primary completion
- Dec 2021
- Modality
- Cytokines & Interferons
01
Overview
A Phase 2 trial of anakinra in allergic asthma, sponsored by University of North Carolina at Chapel Hill. Planned start Aug 2019; status: withdrawn.
02
Drugs
anakinra
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT03513471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03513471.